ClinicalTrials.govpublic full text
Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC
non-small cell lung cancer metastatic, egfr activating mutation, advanced non-small cell lung cancer (nsclc), egfr mutation, gefitinib, chemotherapy, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 871379
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.